We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.54%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$456M
AUM Growth
–
Cap. Flow
+$402M
Cap. Flow
% of AUM
88.16%
Top 10 Holdings %
Top 10 Hldgs %
40.34%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$26.5M |
| 2 |
United Rentals
URI
|
+$25.7M |
| 3 |
Pfizer
PFE
|
+$21M |
| 4 |
LINE
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
|
+$18.7M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$17.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.28% |
| 2 | Healthcare | 19.5% |
| 3 | Energy | 12.28% |
| 4 | Consumer Discretionary | 11.75% |
| 5 | Technology | 11.41% |
Similar funds
RAM
JWBC
PL
SCM
LGP
WI
LAM
ACP
Ardsley Advisory Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ardsley Advisory Partners, which disclosed 131 positions worth $456M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is Jazz Pharmaceuticals: 433,500 shares worth $29.8M.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, followed by Healthcare and Energy.
- Ardsley Advisory Partners's largest Q2 2013 buy was Jazz Pharmaceuticals: 433,500 shares worth $29.8M.
- Ardsley Advisory Partners's ten largest holdings make up 40% of its $456M portfolio in Q2 2013.
- Ardsley Advisory Partners disclosed 131 positions in Q2 2013, its first 13F filing on record.
Based on Ardsley Advisory Partners's 13F filing for Q2 2013, filed 14 Aug 2013.